Home Top Movers Jiuzi Holdings, Inc. (JZXN) Stock Surges Shortly After its Initial Public Offering...

Jiuzi Holdings, Inc. (JZXN) Stock Surges Shortly After its Initial Public Offering Closes

Jiuzi Holdings, Inc. (JZXN) stock prices were up by a promising 23.85% as of the market opening on May 21st, 2021, bringing the price per share up to $0.19 shortly after the trading day commenced.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Closing of IPO

The company announced on May 20th, 2021 the closing of its initial public offering (IPO) of common shares for sale, which had started trading on the Nasdaq Capital Market on May 18th, 2021 under the ticker symbol JZXN. The Chinese energy vehicles franchisor and retailer offered up to 5.2 million shares of its common stock for sale at a price of USD$5 per share. The company forecasts receiving aggregate gross proceeds amounting to USD$26 million before the deduction of expenses related to the offering.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Success of SAVE-MORE

May 20th also saw JZXN report positive day 28 full results from its SAVE-MORE study that focused on hospitalized Covid-19 patients with poor prognosis. The study confirmed the early and targeted use of anakinra as resulting in a 55% relative reduction in mortality and a nearly threefold benefit in preventing progression to severe respiratory failure (SRF).

Efficacy of Anakinra

The treatment also reported an increase in the number of patients discharged from hospitals with no evidence of Covid-19 infection, with patients who received the treatment being 2.8 times more likely to fully recover than patients who had received the placebo. The study included over 600 patients, with the results having been released on MedRxiv and submitted for peer-reviewed publication.

Identifying Unmet Needs

In light of excessive inflammatory responses being a leading cause of disease progression and mortality in Covid-19 cases, JZXN identified an urgent need for medications that target this facet of the illness and prevent its evolution. The highly promising results from early treatment are a critical juncture in the commercialization of anakinra as a treatment during the global pandemic.

Specifics of Anakinra

Patients infected with Covid-19 can suffer severe symptoms which can lead to death on account of an overreaction of the infected patient’s inflammatory response. This phenomenon, often referred to as a cytokine storm, is what anakinra targets in its anti-inflammatory capacity. The drug targets specific cytokines which play an essential role in hyperinflammation induced by Covid-19. To date, no other drug has been approved for the treatment of the Covid-19 inflammatory response.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for JZXN

Armed with a solid liquidity position owing to their successful IPO, JZXN is poised to capitalize on the success of its SAVE-MORE study and push for the commercialization of anakinra. Current and potential investors are hopeful that the commercialization of the first-of-its-kind drug will lead to significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Vista Gold Corp. (VGZ) stock soars during pre-market trading. Here’s what you should know

Vista Gold Corp. (NASDAQ: VGZ) stock gained by 17.65% in the pre-market trading session. Vista is a project developer with a gold rating. The...

Novan Inc. (NOVN) stock soars during pre-market trading. What’s driving it high?

Novan Inc. (NASDAQ: NOVN) stock gained by 62.39% at last close whereas the NOVN stock price surged by 0.82% in the pre-market trading session....

REV Group Inc. (REVG) stock rises during pre-market trading. Let’s see why?

REV Group Inc. (NASDAQ: REVG) stock declined by 0.94% at the last close while the REVG stock price gains by 4.1% in the pre-market...

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Enochian Biosciences, Inc. (ENOB) stock Skyrocketed today?

Shares of the Enochian Biosciences, Inc. (ENOB) stock had skyrocketed today on June 14, 2021, following the announcement of FDA acceptance of Pre-IND request...

Vista Gold Corp. (VGZ) stock soars during pre-market trading. Here’s what you should know

Vista Gold Corp. (NASDAQ: VGZ) stock gained by 17.65% in the pre-market trading session. Vista is a project developer with a gold rating. The...

Orphazyme A/S (ORPH) stock is Popping High in Pre-Market today: Here’s to know Why?

Shares of Orphazyme A/S (ORPH) stock were popping high in the pre-market today on June 14, 2021, after dropping with more than half of...

Related News

RAPT Therapeutics Inc. (RAPT) stock soars during current market trading. Stated below is the update

RAPT Therapeutics Inc. (NASDAQ: RAPT) stock gained by 85.46% in the current market trading. RAPT Therapeutics is a clinical-stage immunology-based pharmaceutical business focusing on...

Why Enochian Biosciences, Inc. (ENOB) stock Skyrocketed today?

Shares of the Enochian Biosciences, Inc. (ENOB) stock had skyrocketed today on June 14, 2021, following the announcement of FDA acceptance of Pre-IND request...

Why is Aptose Biosciences Inc. (APTO) stock gaining today?

Shares of the Aptose Biosciences Inc. (APTO) stock were gaining in the pre-market session today on June 14, 2021, despite no recent activity by...

Sorrento Therapeutics Inc. (SRNE) stock gained during after-hours. Here’s what you should know

Sorrento Therapeutics Inc. (NASDAQ: SRNE) stock surged by 1.6% at the last close while the SRNE stock price rises by 5.07% in the after-hours...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam